Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Other Non-Current Assets (2021 - 2024)

Praxis Precision Medicines has reported Other Non-Current Assets over the past 4 years, most recently at $416000.0 for Q4 2024.

  • For Q4 2024, Other Non-Current Assets changed 0.0% year-over-year to $416000.0; the TTM value through Dec 2024 reached $416000.0, changed 0.0%, while the annual FY2024 figure was $416000.0, 0.0% changed from the prior year.
  • Other Non-Current Assets for Q4 2024 was $416000.0 at Praxis Precision Medicines, roughly flat from $416000.0 in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $472000.0 in Q4 2021 and troughed at $416000.0 in Q1 2022.
  • A 4-year average of $420307.7 and a median of $416000.0 in 2022 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: fell 11.86% in 2022 and later changed 0.0% in 2023.
  • Year by year, Other Non-Current Assets stood at $472000.0 in 2021, then decreased by 11.86% to $416000.0 in 2022, then changed by 0.0% to $416000.0 in 2023, then changed by 0.0% to $416000.0 in 2024.
  • Business Quant data shows Other Non-Current Assets for PRAX at $416000.0 in Q4 2024, $416000.0 in Q3 2024, and $416000.0 in Q2 2024.